Cite
HARVARD Citation
Stets, R. et al. (n.d.). A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of IV to Oral Omadacycline to Moxifloxacin for the Treatment of Adult Subjects with CABP (The OPTIC Study). Open forum infectious diseases. pp. S543-S544. [Online].